Cyclin G2 Antikörper (C-Term)
(1 reference)-
- Target Alle Cyclin G2 (CCNG2) Antikörper anzeigen
- Cyclin G2 (CCNG2)
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Cyclin G2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)
- Spezifität
- CCNG2 Antibody detects endogenous levels of total CCNG2.
- Homologie
- Bovine,Horse,Sheep,Rabbit,Dog,Chicken
- Aufreinigung
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogen
- A synthesized peptide derived from human CCNG2, corresponding to a region within C-terminal amino acids.
- Isotyp
- IgG
- Top Product
- Discover our top product CCNG2 Primärantikörper
-
anti-Cyclin G2 (CCNG2) (AA 151-250) antibody
CCNG2 Reaktivität: Human, Maus, Ratte, Schwein, Kaninchen WB, ELISA, IF (cc), IF (p), ICC, IHC (fro), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin G2 (CCNG2) (AA 1-344) antibodyCCNG2 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 1F9-C11 unconjugated
anti-Cyclin G2 (CCNG2) (N-Term) antibodyCCNG2 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin G2 (CCNG2) (N-Term) antibodyCCNG2 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:500-1:2000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Haltbarkeit
- 12 months
-
-
: "LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway." in: Journal of experimental & clinical cancer research : CR, Vol. 36, Issue 1, pp. 194, (2018) (PubMed).
-
: "LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway." in: Journal of experimental & clinical cancer research : CR, Vol. 36, Issue 1, pp. 194, (2018) (PubMed).
-
- Target
- Cyclin G2 (CCNG2)
- Andere Bezeichnung
- CCNG2 (CCNG2 Produkte)
- Synonyme
- MGC83944 antikoerper, cyclin G2 antikoerper, cyclin G2 S homeolog antikoerper, CCNG2 antikoerper, ccng2.S antikoerper, Ccng2 antikoerper
- Hintergrund
-
Description: May play a role in growth regulation and in negative regulation of cell cycle progression.
Gene: CCNG2
- Molekulargewicht
- 39 kD
- Gen-ID
- 901
- UniProt
- Q16589
-
